Related Experiment Video
Updated: Feb 1, 2026

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic
Nuha Mahmoud1, Mohamed E M Saeed1, Yoshikazu Sugimoto2
1Department of Pharmaceutical Biology, Johannes Gutenberg University, Mainz, Germany.
Abstract:
Nimbolide is considered a promising natural product in cancer prevention and treatment. However, it is not known yet, whether the different mechanisms of multidrug resistance (MDR) influence its anticancer activity. In this study, well-known MDR mechanisms (ABCB1, ABCG2, ABCB5, TP53, EGFR) were evaluated against nimbolide. The P-glycoprotein (ABCB1/MDR1)-overexpressing CEM/ADR5000 cell line displayed remarkable hypersensitivity to nimbolide, which was mediated through upregulation of the tumor suppressor, PTEN, and its downstream components resulted in significant downregulation in ABCB1/MDR1 mRNA and P-glycoprotein. In addition, nimbolide targeted essential cellular metabolic-regulating elements including HIF1α, FoxO1, MYC and reactive oxygen species. The expression of breast cancer resistance protein (BCRP) as well as epidermal growth factor receptor (EGFR) and mutant tumor suppressor TP53 did not correlate to nimbolide's activity. Furthermore, this paper looked for other molecular determinants that might determine tumor cellular response towards nimbolide. COMPARE and hierarchical cluster analyses of transcriptome-wide microarray-based mRNA expressions of the NCI 60 cell line panel were performed, and a set of 40 genes from different functional groups was identified. The data suggested NF-κB as master regulator of nimbolide's activity. Interestingly, HIF1α was determined by COMPARE analysis to mediate sensitivity to nimbolide, which would be of great benefit in targeted therapy.
Insights
Nimbolide shows enhanced anticancer activity in cells overexpressing P-glycoprotein (ABCB1/MDR1), mediated by PTEN upregulation. This natural product also targets key metabolic regulators like HIF1α, suggesting potential in targeted cancer therapy.
Area of Science:
- Natural product chemistry
- Cancer biology
- Molecular pharmacology
Background:
- Nimbolide is a promising natural product for cancer treatment.
- Mechanisms of multidrug resistance (MDR) can impact anticancer drug efficacy.
- Understanding nimbolide's interaction with MDR is crucial for its therapeutic application.
Purpose of the Study:
- To investigate the influence of known multidrug resistance (MDR) mechanisms on nimbolide's anticancer activity.
- To identify molecular determinants of tumor cellular response to nimbolide.
- To explore nimbolide's potential in targeted cancer therapy.
Main Methods:
- Evaluation of nimbolide against cell lines with known MDR mechanisms (ABCB1, ABCG2, ABCB5, TP53, EGFR).
- Analysis of gene expression changes (mRNA and protein) in response to nimbolide treatment.
- COMPARE and hierarchical cluster analyses of transcriptome-wide microarray data from the NCI 60 cell line panel.
Main Results:
- Hypersensitivity to nimbolide was observed in P-glycoprotein (ABCB1/MDR1)-overexpressing cells, linked to PTEN upregulation and ABCB1/MDR1 downregulation.
- Nimbolide targeted metabolic regulators including HIF1α, FoxO1, and MYC, and affected reactive oxygen species.
- Expression of ABCG2, EGFR, and mutant TP53 did not correlate with nimbolide's activity.
- NF-κB was identified as a master regulator, and HIF1α as a mediator of nimbolide sensitivity.
Conclusions:
- Nimbolide's efficacy is influenced by specific MDR mechanisms, particularly P-glycoprotein.
- Nimbolide exhibits a multifaceted mechanism of action, targeting cellular metabolism and key regulatory pathways.
- HIF1α's role in mediating nimbolide sensitivity highlights its potential for targeted cancer therapy.
More Related Videos
06:16Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
Related Concept Videos
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
What is Metabolism?
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Resistivity
Resistance
Equivalent Resistance